Business Overview
American HealthCare Capital is pleased to exclusively introduce a premier, hyper-explosive direct-to-consumer (DTC) telehealth and medical software platform focused on the booming weight-loss and GLP-1 wellness markets. Launched in 2023, the company has achieved a market position by executing an entirely vertically integrated digital health model. Unlike traditional resellers or affiliate aggregators, this company owns its consumer brand, its Management Services Organization (MSO) layer, its compliant clinical provider architecture (Professional Corporation infrastructure), and a proprietary end-to-end technology stack.
Operating on a 100% cash-pay/private subscription model, the platform eliminates all insurance reimbursement complexities and regulatory payer dependencies. The platform is fully LegitScript certified and maintains direct, contractually secure fulfillment relationships with leading compounding pharmacy partners across all 50 states. This structure gives the business agility regarding pricing, product sourcing, and margin protection that competitors cannot structurally match.
Operational & Growth Profile
- Predictable Recurring Revenue: The platform commands a highly stable, recurring book of 10,000+ active patients on monthly subscription plans, featuring an average initial patient lifetime value (LTV) of 6 months.
- Proprietary Technology Stack: The company owns its software architecture end-to-end—including custom customer acquisition funnels, dynamic medical intake quizzes, secure checkout processing, automated subscription management, and provider support tooling.
- Self-Sustaining Marketing Engine: Customer acquisition is driven by a highly optimized, dual-engine channel blend (predominantly Meta advertising alongside organic social channels), further supercharged by a proprietary internal affiliate network and an active creator program consisting of over 100 influencer partnerships that drive ~20% of all platform revenue.
- Lean, High-Leverage Staffing: Operations are engineered for extreme capital efficiency, utilizing a lean corporate headcount of 2 W2 payroll employees and 6 core independent subcontractors to manage millions in monthly transaction volume.
Financial Overview
The financial trajectory of the company represents a premier growth story in digital healthcare. Moving from an initial launch footprint of just $286 in revenue in 2023, the platform expanded to $4,402,984.97 in 2024, and exploded to $12,381,424.16 in 2025.
This momentum has accelerated through fiscal year 2026. For the first five months of 2026 alone, the platform captured $14,148,619.87 in actual year-to-date revenue. On-track run-rate trends place the company on a clear path to achieve $33,956,687.69 in projected full-year 2026 revenue, yielding an outstanding $10,114,494.59 in projected net profitability (representing a ~30% net income margin profile).
Financial Performance & Growth Drivers
The platform’s financial performance highlights clear, scalable velocity. For fiscal year-end 2025, the company achieved an audited gross revenue of more than $12.38 million. After applying standard adjustments for non-recurring, discretionary, and ownership overhead, the platform generated a true Adjusted EBITDA of nearly $2.10 million.
Asking Price
The final purchase price will be determined through discussions with qualified buyers based on market feedback and overall deal structure.